Advertisement

Topics

Blueprint Medicines To Present Updated Data From Ongoing Phase I Clinical Trial Of BLU-554 In Patients With Advanced Hepatocellular Carcinoma At 2017 Congress And 11th Annual Conference

20:00 EDT 21 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Blueprint Medicines To Present Updated Data From Ongoing Phase I Clinical Trial Of BLU-554 In Patients With Advanced Hepatocellular Carcinoma At 2017 Congress And 11th Annual Conference

NEXT ARTICLE

More From BioPortfolio on "Blueprint Medicines To Present Updated Data From Ongoing Phase I Clinical Trial Of BLU-554 In Patients With Advanced Hepatocellular Carcinoma At 2017 Congress And 11th Annual Conference"

Advertisement
Quick Search
Advertisement
Advertisement